The CD19 negative DLBCL were characterized further for other B cell lineage and lymphoma markers including CD20, PAX5, CD138, BCL2, BCL6, BCL10 and MUM1 using immunohistochemistry (Table 2). Here, BCL6 is linked to lymphoma.